Seroepidemiology and Risk Factors of Toxoplasma gondii in Iranian COVID-19 Patients: A Case-Control Study

Despite the non-significant association between the chronic phase of <i>T. gondii</i> (sero) prevalence and COVID-19 symptomatic forms, the parasite prevalence was estimated remarkable and the viral infection and parasite-related acute phase antibodies relationship was estimated to be statistically significant. Due to immunosuppressive therapies for this viral inflammatory infection, it makes it more difficult to interpret the results, and because of the vulnerability of the immune system of these individuals, toxoplasmosis is likely to be hazardous in them; therefore, screening for this parasitic complication seems necessary.